Citation only
via Europe PMC
Potential role of irisin-mediated oxidative stress defense in systemic diseases.
Frontiers in cell and developmental biology · 2026
Abstract
Oxidative stress arises when excessive reactive oxygen species (ROS) overwhelm endogenous antioxidant defenses, leading to deleterious modifications of lipids, proteins, and DNA. Persistent oxidative stress is implicated in the pathogenesis of numerous chronic disorders, including cardiovascular diseases, neurodegenerative conditions, type 2 diabetes mellitus, and ischaemia-reperfusion (I/R) injury across multiple organs. Irisin, a myokine/adipokine proteolytically cleaved from fibronectin type III domain-containing protein 5 (FNDC5), was first characterized in 2012. Preclinical studies have increasingly demonstrated that irisin possesses potent antioxidant properties and exerts cytoprotective effects in diverse tissues. These antioxidant actions are mediated through multiple molecular mechanisms: activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway with subsequent upregulation of cytoprotective enzymes such as haem oxygenase-1 (HO-1); sirtuin 3 (SIRT3)-dependent deacetylation and activation of mitochondrial superoxide dismutase 2 (SOD2); inhibition of pro-oxidant enzymes including NADPH oxidase (NOX); and modulation of mitochondrial fusion-fission dynamics to preserve mitochondrial homeostasis. Functionally, irisin initiates intracellular signalling cascades, including AMP-activated protein kinase (AMPK), PI3K/Akt, and MAPK pathways, primarily through binding to cell-surface integrin αV receptors. This review systematically summarizes the molecular mechanisms underlying irisin-mediated antioxidation, delineates its organ-protective roles in cardiovascular, neurological, metabolic, hepatic, renal, pulmonary, gastrointestinal, skeletal, reproductive systems, as well as in sepsis and ageing, and discusses its translational potential as a clinical biomarker and therapeutic target for oxidative-stress-associated diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fcell.2026.1996659
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
X, X., L, W., X, Z., & J., Z. (2026). Potential role of irisin-mediated oxidative stress defense in systemic diseases. <em>Frontiers in cell and developmental biology</em>. https://doi.org/10.3389/fcell.2026.1996659
Vancouver
X X, L W, X Z, J. Z. Potential role of irisin-mediated oxidative stress defense in systemic diseases. Frontiers in cell and developmental biology. 2026. doi:10.3389/fcell.2026.1996659.
BibTeX
@article{xiao2026Potent,
title = {Potential role of irisin-mediated oxidative stress defense in systemic diseases.},
author = {Xiao X and Wu L and Zhu X and Zhou J.},
journal = {Frontiers in cell and developmental biology},
year = {2026},
doi = {10.3389/fcell.2026.1996659},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Archives of Toxicology 2023
Open access · CC-BY
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
Journal of Ovarian Research 2022
Open access · CC-BY
The role of oxidative stress in ovarian aging: a review
Antioxidants 2023
Open access · CC-BY
Aging Hallmarks and the Role of Oxidative Stress
Cells 2026
Open access · OA
Fanconi Anemia: Interplay Between DNA Repair Defects, Mitochondrial Dysfunction, and Oxidative Stress.
Biomolecules 2025
Open access · CC-BY
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Fitoterapia 2026
Citation only